Biotechnological production of sialylated solid lipid microparticles as inhibitors of influenza A virus infection.
Sign Up to like & getrecommendations! Published in 2022 at "Glycobiology"
DOI: 10.1093/glycob/cwac054
Abstract: Influenza viruses bind to their target through a multivalent interaction of their hemagglutinins with sialosides at the host cell surface. To fight the virus, one therapeutic approach consists in developing sialylated multivalent structures that can… read more here.
Keywords: biotechnological production; solid lipid; lipid microparticles; production ... See more keywords